A Study of DCDT2980S and DCDS4501A Combined with Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Update Il y a 4 ans
Reference: EUCTR2011-004377-84

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Safety and tolerability and anti-tumor activity of DCDT2908S combined with Rituximab and DCDS4501A combined with Rituximab.


Inclusion criteria

  • Follicular Non-Hodgkin's Lymphoma (FL); Diffuse Large B-Cell
  • Lymphoma (DLBCL)